Doctor Anywhere posts healthier operations in 2025

Tech-enabled healthcare platform Doctor Anywhere (DA) is looking healthier.

The platform recorded S$1.1 million (US$868,000) in operating profit for the 2025 fiscal year, the first time it hit a positive in four years, according to its latest audited financial statement. It’s a clear recovery from its operating loss of S$35.9 million (US$28 million) in the previous period.

Doctor Anywhere founder Wai Mun Lim. / Photo credit: Doctor Anywhere

CEO Wai Mun Lim tells Tech in Asia that 2025 was Doctor Anywhere’s “defining year.” He says the startup focused on driving “sustainable, profitable growth” by phasing out underperforming units and concentrating resources on “where they generate the highest impact.”

In November 2025, DA announced it had ended its operations in Vietnam after almost six years in the country. It said the move was part of the company’s bid to “focus on scaling in our core markets.” At present, the firm remains operational in Singapore, the Philippines, Thailand, Malaysia, and Indonesia.

Patient and related services, which include doctor consultations, clinic treatments, and medical tests and health screenings, drove the majority of the firm’s revenue in 2025. While revenue growth slowed by 5% year on year, it was the highest the company had seen at S$91.1 million (US$71 million).

“It helps that the healthcare industry remains a pretty resilient sector,” Chaitanya Puri, CFO of Doctor Anywhere, tells Tech in Asia. The firm is optimistic it will continue to grow at its “current, similar trajectory.”

From D2C to B2B

Founded in 2017, the healthtech startup began as a consumer-facing telehealth platform before becoming a full-fledged hybrid clinic in Singapore. It works with health insurance providers across all its markets.

In Singapore, it offers specialist, preventive care, and home care services. The latter allows customers to book anything from simple to complex healthcare needs, like doctor house calls and legal and medical planning certifications.

The firm has also actively pursued partnerships with health insurance providers across the five markets it is in, giving them access to its telehealth platform for a fee. In the Philippines, for instance, certain health cards have partnered with DA, allowing their customers to access the telehealth platform’s specialists online as part of the benefits they get from providers.

DA nurses at the DA clinic in Potong Pasir, Singapore / Photo credit: Doctor Anywhere

The healthtech startup, however, declined to share how much its B2B operations contribute to its revenue. CFO Puri contends that both its direct-to-consumer (D2C) and B2B operations remain integral to the business.

“It doesn’t have to be a choice between B2B or D2C. This is about DA assessing the market and putting resources where we think we give the best value to the market, and the best ROI,” Puri adds.

Hitting the 10-year mark